The earnings call reflects a generally positive sentiment with strong revenue growth, successful product launches, and significant international expansion. However, there are challenges, including a decline in U.S. clinical visits and pressures from the macroeconomic and trade environment.

Company Guidance -

Q2 2025

During the IDEXX Laboratories' first quarter 2025 earnings call, CFO Andrew Emerson reported a 5% organic revenue growth, driven by a 4.5% increase in CAG Diagnostic recurring revenues and a 9% growth in both veterinary software and diagnostic imaging. Despite a 2.6% decline in U.S. clinical visits, IDEXX achieved an EPS of $2.96, reflecting a 5% increase as reported and a 7% growth on a comparable basis. The company placed 4,163 CAG premium instruments, although this represented a 13% decline from the previous year, with U.S. placements up by 12%. IDEXX sustained a strong customer base, with a 9% rise in the global premium instrument installed base, and maintained a 7% organic growth in water and 4% in livestock, poultry, and dairy revenues. The company updated its 2025 outlook to account for foreign exchange benefits and concluded litigation expenses while holding its full-year organic growth forecast at 6% to 9%.

Solid Start to 2025

IDEXX achieved a solid start to 2025 with overall revenues increasing 5% organically, supported by a 4.5% organic growth in CAG Diagnostic recurring revenues.

Strong International Growth

International CAG diagnostic recurring revenue organic growth was 8.5%, reflecting benefits from net price realization and strong volume gains.

EPS and Profit Growth

EPS delivery was $2.96 per share, delivering 5% growth as reported and 7% growth on a comparable basis.

Expansion in Premium Instrument Install Base

IDEXX achieved a 9% expansion of the premium instrument install base and placed 1,544 instruments in the U.S., an increase of 12% year-over-year.

Launch of IDEXX Cancer Dx

IDEXX launched IDEXX Cancer Dx for early detection of canine lymphoma, with over 1,000 practices ordering the test within a month of launch.

Continued Innovation with IDEXX inVue Dx

Strong pre-order momentum and successful controlled launch of IDEXX inVue Dx, with over 900 placements through the end of April, transitioning to full launch.

Strong Software Ecosystem Performance

Veterinary software and diagnostic imaging revenues increased 9%, driven by reoccurring revenues and momentum in cloud-based software placements.

Resilient Pet Population

Estimated pet population sustained in 2024 at similar levels to the prior year, representing approximately 3% CAGR versus 2019 baseline.

Idexx Laboratories (IDXX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

IDXX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 04, 2025	2025 (Q2)	3.30 / -	2.44	―	―	―
May 01, 2025	2025 (Q1)	2.85 / 2.96	2.81	5.34% (+0.15)
Feb 03, 2025	2024 (Q4)	2.40 / 2.62	2.32	12.93% (+0.30)
Oct 31, 2024	2024 (Q3)	2.68 / 2.80	2.53	10.67% (+0.27)
Aug 06, 2024	2024 (Q2)	2.88 / 2.44	2.67	-8.61% (-0.23)
May 01, 2024	2024 (Q1)	2.71 / 2.81	2.55	10.20% (+0.26)
Feb 05, 2024	2023 (Q4)	2.12 / 2.32	2.05	13.17% (+0.27)
Nov 01, 2023	2023 (Q3)	2.37 / 2.53	2.15	17.67% (+0.38)
Aug 01, 2023	2023 (Q2)	2.47 / 2.67	1.56	71.15% (+1.11)
May 02, 2023	2023 (Q1)	2.42 / 2.55	2.27	12.33% (+0.28)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

IDXX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 01, 2025	$432.65	$471.38	+8.95%
Feb 03, 2025	$422.05	$469.04	+11.13%
Oct 31, 2024	$451.08	$406.92	-9.79%
Aug 06, 2024	$455.08	$469.37	+3.14%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Idexx Laboratories (IDXX) report earnings?

Idexx Laboratories (IDXX) is schdueled to report earning on Aug 04, 2025, Before Open (Confirmed).

What is Idexx Laboratories (IDXX) earnings time?

Idexx Laboratories (IDXX) earnings time is at Aug 04, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is IDXX EPS forecast?

IDXX EPS forecast for the fiscal quarter 2025 (Q2) is 3.3.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing